← Leaderboards
Cheryl A London
University Of California Davis
$14,382,535
Attributed
$20,887,332
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,115,026 · 12
By mechanism
U01$8,575,953 · 3
R01$8,165,247 · 4
UC7$7,227,694 · 1
RC2$2,512,809 · 1
P01$1,186,917 · 1
T35$354,354 · 1
Top collaborators
- Elinor Karlsson8 shared
- Iris Z Jaffe5 shared
- Jillian M Richmond5 shared
- Steven W. Dow4 shared
- Kelly Ann Metcalf Pate4 shared
- Sam R. Telford3 shared
- Alexander Bick1 shared
Most similar at University Of California Davis
Same institution · by research overlap
- Michael Steven Denison$8,697,356
- Laura S Van Winkle$14,575,573
- Charles G. Plopper$12,139,766
Others in their field
Top investigators on “Future”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$274,284,003
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$246,289,043
Research focus
FutureSamplingCanis FamiliarisMalignant NeoplasmsProspectiveBiological MarkersBiological ModelsTumorResponseEnsureBloodExhibitsDesignAnimal ModelClinical TrialsOsteosarcomaImmunotherapyPreventEvaluationPlasmaImmune Checkpoint InhibitorResourcesPharmaceutical PreparationsProtocols Documentation
Grant awards (45)
Resources and workforce development for the New England Regional Biosafety Laboratory$2,363,198
UC7 · FY2025 · AI
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention$815,091
RC2 · FY2025 · TR · contact PI
Modelling the dynamics of spontaneous clonal hematopoiesis in pet dogs during cancer therapy$742,391
R01 · FY2025 · CA · contact PI
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$592,532
U01 · FY2025 · CA · contact PI
Leveraging canine spontaneous cancer to optimize the power of blood biopsy$582,347
R01 · FY2025 · CA
Cross-Disciplinary Research Training for Veterinary Students$99,863
T35 · FY2025 · OD · contact PI
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$76,725
U01 · FY2025 · CA · contact PI
Resources and workforce development for the New England Regional Biosafety Laboratory$2,429,378
UC7 · FY2024 · AI
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention$821,833
RC2 · FY2024 · TR · contact PI
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$683,986
U01 · FY2024 · CA · contact PI
Leveraging canine spontaneous cancer to optimize the power of blood biopsy$558,828
R01 · FY2024 · CA
Cross-Disciplinary Research Training for Veterinary Students$88,504
T35 · FY2024 · OD · contact PI
Resources and workforce development for the New England Regional Biosafety Laboratory$2,435,118
UC7 · FY2023 · AI
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention$875,885
RC2 · FY2023 · TR · contact PI
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$657,791
U01 · FY2023 · CA · contact PI
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$597,582
R01 · FY2023 · CA
Leveraging canine spontaneous cancer to optimize the power of blood biopsy$573,297
R01 · FY2023 · CA
Connecting individual-level environmental exposures to cancer-related outcomes in a shorter-lived natural model system$100,001
R01 · FY2023 · CA
Cross-Disciplinary Research Training for Veterinary Students$85,739
T35 · FY2023 · OD · contact PI
Leveraging canine spontaneous cancer to optimize the power of blood biopsy$44,963
R01 · FY2023 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$645,473
U01 · FY2022 · CA · contact PI
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$617,870
R01 · FY2022 · CA
Leveraging canine spontaneous cancer to optimize the power of blood biopsy$590,812
R01 · FY2022 · CA
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma$552,171
U01 · FY2022 · CA
Cross-Disciplinary Research Training for Veterinary Students$80,248
T35 · FY2022 · OD · contact PI
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches$696,529
U01 · FY2021 · CA · contact PI
Leveraging canine spontaneous cancer to optimize the power of blood biopsy$645,307
R01 · FY2021 · CA
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$614,697
R01 · FY2021 · CA
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma$1
U01 · FY2021 · CA
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches$699,639
U01 · FY2020 · CA · contact PI
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$661,594
R01 · FY2020 · CA
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma$553,260
U01 · FY2020 · CA
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$644,071
R01 · FY2019 · CA
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches$1,745,768
U01 · FY2017 · CA · contact PI
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma$1,672,078
U01 · FY2017 · CA
COMPARTIVE ANIMAL CORE$249,555
P01 · FY2017 · CA · contact PI
COMPARTIVE ANIMAL CORE$246,330
P01 · FY2016 · CA · contact PI
COMPARTIVE ANIMAL CORE$233,851
P01 · FY2015 · CA · contact PI
COMPARTIVE ANIMAL CORE$223,901
P01 · FY2014 · CA · contact PI
COMPARTIVE ANIMAL CORE$233,280
P01 · FY2013 · CA · contact PI
c-Kit Mutations and Their Role in Tumor Biology$299,374
R01 · FY2005 · CA
c-Kit Mutations and Their Role in Tumor Biology$297,371
R01 · FY2004 · CA
c-Kit Mutations and Their Role in Tumor Biology$297,371
R01 · FY2003 · CA
c-Kit Mutations and Their Role in Tumor Biology$297,371
R01 · FY2002 · CA
T LMPHOCYTE MEMORY$92,052
K01 · FY2000 · RR